|
CN104278037B
(zh)
|
2005-10-12 |
2020-09-15 |
艾德拉药物股份有限公司 |
基于变异应答调制Toll样受体的免疫调节寡核苷酸(IRO)化合物
|
|
CN101801401A
(zh)
*
|
2007-03-16 |
2010-08-11 |
佛罗里达大学研究基金会 |
激酶蛋白质结合抑制剂
|
|
EP2349271A2
(en)
*
|
2008-10-06 |
2011-08-03 |
Idera Pharmaceuticals, Inc. |
Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto
|
|
SG171914A1
(en)
|
2008-12-02 |
2011-07-28 |
Chiralgen Ltd |
Method for the synthesis of phosphorus atom modified nucleic acids
|
|
US20100233270A1
(en)
|
2009-01-08 |
2010-09-16 |
Northwestern University |
Delivery of Oligonucleotide-Functionalized Nanoparticles
|
|
WO2010088395A2
(en)
*
|
2009-01-30 |
2010-08-05 |
Idera Pharmaceuticals, Inc. |
Novel synthetic agonists of tlr9
|
|
CN103800906B
(zh)
|
2009-03-25 |
2017-09-22 |
德克萨斯大学系统董事会 |
用于刺激哺乳动物对病原体的先天免疫抵抗力的组合物
|
|
US9744183B2
(en)
|
2009-07-06 |
2017-08-29 |
Wave Life Sciences Ltd. |
Nucleic acid prodrugs and methods of use thereof
|
|
US20110009477A1
(en)
*
|
2009-07-08 |
2011-01-13 |
Idera Pharmaceuticals, Inc. |
Oligonucleotide-based compounds as inhibitors of toll-like receptors
|
|
US10363251B2
(en)
|
2009-07-16 |
2019-07-30 |
Mallinckrodt Llc |
(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
|
|
CA2768236C
(en)
*
|
2009-07-16 |
2018-05-22 |
Mallinckrodt Llc |
(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
|
|
ES2538347T3
(es)
*
|
2009-08-27 |
2015-06-19 |
Idera Pharmaceuticals, Inc. |
Composiciones para inhibir expresión genética y usos de las mismas
|
|
WO2011041311A2
(en)
*
|
2009-09-29 |
2011-04-07 |
Yale University |
Compositions and methods for inhibiting inflammation from and rejection of biomaterials and other methods
|
|
JP2011084517A
(ja)
*
|
2009-10-15 |
2011-04-28 |
Koreaki Taniguchi |
核酸により活性化される自然免疫応答の抑制剤及びスクリーニング方法
|
|
US20130079505A1
(en)
*
|
2010-03-24 |
2013-03-28 |
Mirrx Therapeutics A/S |
Bivalent antisense oligonucleotides
|
|
WO2012008984A1
(en)
|
2010-07-16 |
2012-01-19 |
Mallinckrodt Llc |
(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
|
|
GB201014026D0
(en)
*
|
2010-08-20 |
2010-10-06 |
Ucl Business Plc |
Treatment
|
|
EP2617426B1
(en)
|
2010-09-17 |
2016-08-10 |
Japan Science and Technology Agency |
Inhibitor of hmgb protein-mediated immune response activation
|
|
DK2620428T3
(da)
|
2010-09-24 |
2019-07-01 |
Wave Life Sciences Ltd |
Asymmetrisk hjælpegruppe
|
|
EP2640420B1
(en)
|
2010-11-19 |
2018-08-15 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
|
|
GB201022049D0
(en)
*
|
2010-12-29 |
2011-02-02 |
Imp Innovations Ltd |
Methods
|
|
US8877722B2
(en)
|
2011-03-25 |
2014-11-04 |
Idera Pharmaceuticals, Inc. |
Compositions for inhibiting gene expression and uses thereof
|
|
CN108853403A
(zh)
*
|
2011-05-16 |
2018-11-23 |
豪斯生物药业公司 |
特定草药制剂的治疗性组合物及其用途
|
|
RU2014105311A
(ru)
|
2011-07-19 |
2015-08-27 |
Уэйв Лайф Сайенсес Пте. Лтд. |
Способы синтеза функционализованных нуклеиновых кислот
|
|
EP2756080B1
(en)
|
2011-09-14 |
2019-02-20 |
Translate Bio MA, Inc. |
Multimeric oligonucleotide compounds
|
|
BR112015000723A2
(pt)
*
|
2012-07-13 |
2017-06-27 |
Shin Nippon Biomedical Laboratories Ltd |
adjuvante de ácido nucléico quiral
|
|
PT2872485T
(pt)
|
2012-07-13 |
2021-03-05 |
Wave Life Sciences Ltd |
Grupo auxiliar assimétrico
|
|
KR102712879B1
(ko)
|
2012-07-13 |
2024-10-04 |
웨이브 라이프 사이언시스 리미티드 |
키랄 제어
|
|
CA2884608C
(en)
|
2012-09-14 |
2025-05-20 |
Translate Bio Ma, Inc. |
MULTIMERIC OLIGONUCLEOTIDE COMPOUNDS
|
|
CN103845731B
(zh)
*
|
2012-12-05 |
2015-12-02 |
复旦大学 |
抗st2/il-1r4抗体在制备防治瘙痒药物中的应用
|
|
CN103845730B
(zh)
*
|
2012-12-05 |
2015-12-09 |
复旦大学 |
抗st2/il-1 r4抗体在制备镇痛药物中的用途
|
|
HK1214191A1
(zh)
*
|
2013-01-08 |
2016-07-22 |
Idera Pharmaceuticals, Inc. |
免疫調節寡核苷酸(iro)化合物以調節基於toll樣受體的免疫應答
|
|
US20140234377A1
(en)
*
|
2013-02-05 |
2014-08-21 |
Nitto Denko Corporation |
Vaccine composition for mucosal administration
|
|
GB2514591A
(en)
*
|
2013-05-30 |
2014-12-03 |
Mologen Ag |
Predictive biomarker for cancer therapy
|
|
JPWO2015108047A1
(ja)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
|
|
JPWO2015108048A1
(ja)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
|
|
JPWO2015108046A1
(ja)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤
|
|
PT3094728T
(pt)
|
2014-01-16 |
2022-05-19 |
Wave Life Sciences Ltd |
Desenho quiral
|
|
CN106535876B
(zh)
|
2014-06-04 |
2020-09-11 |
埃克西奎雷股份有限公司 |
免疫调节剂通过脂质体球形核酸的多价递送以用于预防或治疗应用
|
|
WO2016044839A2
(en)
|
2014-09-19 |
2016-03-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
|
|
CA2968531A1
(en)
|
2014-11-21 |
2016-05-26 |
Northwestern University |
The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
|
|
SK500652015A3
(sk)
|
2015-10-15 |
2017-05-03 |
Ústav Polymérov Sav |
Spôsob úpravy funkčného stavu ľubovoľnej mRNA umožňujúci jej selektívne a špecifické rozpoznanie
|
|
CN105541947A
(zh)
*
|
2016-01-11 |
2016-05-04 |
中国人民解放军第三军医大学第一附属医院 |
拮抗tlr7/8及tlr9活化的药物分子及用途
|
|
CN105597079A
(zh)
*
|
2016-01-11 |
2016-05-25 |
中国人民解放军第三军医大学第一附属医院 |
用于治疗银屑病的药物
|
|
CN114807152A
(zh)
|
2016-06-08 |
2022-07-29 |
哈佛学院院长及董事 |
工程化病毒载体减少了炎症和免疫反应的诱导
|
|
US11364304B2
(en)
|
2016-08-25 |
2022-06-21 |
Northwestern University |
Crosslinked micellar spherical nucleic acids
|
|
WO2018089695A1
(en)
|
2016-11-11 |
2018-05-17 |
Dynavax Technologies Corporation |
Toll-like receptor antagonist compounds and methods of use
|
|
BR112019010506A2
(pt)
*
|
2016-11-23 |
2019-09-17 |
Berlin Cures GmbH |
aptâmero para uso em terapia de um indivíduo por inibição e/ou supressão da ativação de tlr9
|
|
WO2018209270A1
(en)
|
2017-05-11 |
2018-11-15 |
Northwestern University |
Adoptive cell therapy using spherical nucleic acids (snas)
|
|
ES2910974T3
(es)
|
2017-07-27 |
2022-05-17 |
Inst Nat Sante Rech Med |
Métodos para determinar si un paciente que padece rabdomiólisis logra una respuesta con un antagonista de TLR9
|
|
US11981911B2
(en)
|
2017-11-08 |
2024-05-14 |
President And Fellows Of Harvard College |
Compositions and methods for inhibiting viral vector-induced inflammatory responses
|
|
BR112020023866A2
(pt)
*
|
2018-05-25 |
2021-04-06 |
Primmune Therapeutics, Inc. |
Agonistas de tlr7
|
|
BR112022010165A2
(pt)
|
2019-11-26 |
2022-08-09 |
Primmune Therapeutics Inc |
Agonistas de tlr7
|
|
IL294621A
(en)
*
|
2020-01-10 |
2022-09-01 |
Sbi Biotech Co Ltd |
Tlr9 agonist oligonucleotides, compositions comprising same and uses thereof
|